Modulation of drug resistance by α-tubulin in paclitaxel-resistant human lung cancer cell lines

Autor: E K, Han, E, Kyu-Ho Han, L, Gehrke, S K, Tahir, R B, Credo, S P, Cherian, H, Sham, S H, Rosenberg, S, Ng
Rok vydání: 2000
Předmět:
Zdroj: European Journal of Cancer. 36:1565-1571
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(00)00145-3
Popis: Beta(beta)-tubulin isotype variation has recently been implicated in the modulation of resistance to paclitaxel in human lung cancer cells and in primary human ovarian tumour samples. Whether alpha-tubulin is involved in drug resistance has not been reported. We have generated a paclitaxel-resistant cell line (H460/T800) from the sensitive human lung carcinoma parental cell line NCI-H460. The resistant cells are more than 1000-fold resistant to taxol and overexpress P-glycoprotein. Interestingly, H460/T800 cells also overexpress alpha- and beta-tubulin as detected by Western blot analysis. From Northern blot analysis, the mechanism of tubulin overexpression appears to be post-transcriptional. To understand whether alpha-tubulin plays a role in drug resistance, we transfected antisense human kalpha1 cDNA construct into the H460/T800 paclitaxel-resistant cells. The antisense clones displayed a reduced alpha-tubulin expression, and the cells were 45-51% more sensitive to paclitaxel and other known antimitotic drugs, compared with vector transfected controls. Complementary experiments of transfecting the sense kalpha1 cDNA into H460 cells conferred a 1.8- to 3.3-fold increase in the IC(50) of several antimitotic agents. Our study suggests that alpha-tubulin is one of the factors that contributes to drug resistance.
Databáze: OpenAIRE